XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019   98,587      
Beginning balance at Dec. 31, 2019 $ 98,905 $ 986 $ 662,990 $ 50 $ (565,121)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options (in shares) 2,956 2,956      
Exercise of stock options $ 21,709 $ 29 21,680    
Vesting of restricted stock units (in shares)   1,504      
Vesting of restricted stock units 0 $ 15 (15)    
Issuance of common stock under employee stock purchase plan (in shares)   668      
Issuance of common stock under employee stock purchase plan 13,040 $ 7 13,033    
Stock-based compensation 59,782   59,782    
Other comprehensive loss (40)     (40)  
Net loss (42,731)       (42,731)
Ending balance (in shares) at Dec. 31, 2020   103,715      
Ending balance at Dec. 31, 2020 $ 150,665 $ 1,037 757,470 10 (607,852)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options (in shares) 2,671 2,671      
Exercise of stock options $ 18,268 $ 26 18,242    
Vesting of restricted stock units (in shares)   1,872      
Vesting of restricted stock units 0 $ 19 (19)    
Issuance of common stock under employee stock purchase plan (in shares)   671      
Issuance of common stock under employee stock purchase plan 13,736 $ 7 13,729    
Stock-based compensation 79,637   79,637    
Other comprehensive loss (316)     (316)  
Net loss $ (46,677)       (46,677)
Ending balance (in shares) at Dec. 31, 2021 108,929 108,929      
Ending balance at Dec. 31, 2021 $ 215,313 $ 1,089 869,059 (306) (654,529)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options (in shares) 1,174 1,174      
Exercise of stock options $ 11,721 $ 12 11,709    
Vesting of restricted stock units (in shares)   2,510      
Vesting of restricted stock units 0 $ 25 (25)    
Issuance of common stock under employee stock purchase plan (in shares)   443      
Issuance of common stock under employee stock purchase plan 14,791 $ 5 14,786    
Stock-based compensation 122,308   122,308    
Other comprehensive loss (1,045)     (1,045)  
Net loss $ (92,222)       (92,222)
Ending balance (in shares) at Dec. 31, 2022 113,056 113,056      
Ending balance at Dec. 31, 2022 $ 270,866 $ 1,131 $ 1,017,837 $ (1,351) $ (746,751)